A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab — Stella
A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(2 sites)
United States
Children's Hospital Los Angeles- Site Number : 8400005, Los Angeles, California
Taiwan
Investigational Site Number : 1580001, Taipei, Podlaskie